Risk factors for tumors or leukemia development in the first two years of life

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Sep;167(3):246-253. doi: 10.5507/bp.2022.004. Epub 2022 Feb 11.

Abstract

Objectives: The objective of this study was to determine the incidence of neoplastic diseases and associated risk factors in the early stages of life.

Methods: Data were retrospectively assessed in 730,000 live births between 2000 and 2019. The occurrence of tumors was monitored in the neonatal, infant (1-12 months), and toddler (13-24 months) periods. Risk factors were divided into demographic, internal, and environmental factors. The control group consisted of subjects in the same age category without oncological diseases.

Results: A total of 452 neoplastic diseases were diagnosed in the study sample. In total, 24% (110/452) manifested during the neonatal period, 45% (203/452) in infants, and 31% (139/452) at the age of 13-24 months. Any genetic disease (OR 26.68; 95% CI 7.64-93.12) and medications used by the mother (OR 3.07; 95% CI 1.32-7.15) were identified as risk factors. Without adjustment for all factors, asphyxia in the first minute, a younger age of the mother, lower pregnancy, and the presence of a congenital defect manifested themselves as risk factors.

Conclusions: The highest risk factors for the development of early childhood tumors were identified as with medications used by the mother before or during pregnancy and genetic diseases.

Keywords: early-aged period; epidemiology; neoplastic disease; risk factors.

MeSH terms

  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Leukemia* / epidemiology
  • Leukemia* / etiology
  • Mothers
  • Neoplasms* / epidemiology
  • Neoplasms* / etiology
  • Pregnancy
  • Retrospective Studies
  • Risk Factors